1-4 of 4
Katie Renn
Close
Sort by
Journal Articles

C/EBPα determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation

Hyung Chan Suh, John Gooya, Katie Renn, Alan D. Friedman, Peter F. Johnson, Jonathan R. Keller
Journal: Blood
Blood (2006) 107 (11): 4308–4316.
https://doi.org/10.1182/blood-2005-06-2216
Published: 2006
Journal Articles

CCAAT Enhancer Binding Protein-α (C/EBPα) Determines Myeloid Versus Erythroid Cell Fate in Multipotential Progenitors.

Hyung-Chan Suh, MD, John Gooya, Katie Renn, Alan Friedman, MD, Peter Johnson, PhD, Jonathan Keller, PhD
Journal: Blood
Blood (2004) 104 (11): 1603.
https://doi.org/10.1182/blood.V104.11.1603.1603
Published: 2004
Journal Articles

Growth Suppressors IFI-204 and IFI-205 Inhibit Primitive Hematopoietic Cell Proliferation In Vitro and in Vivo.

Kimberly Klarmann, Ph.D., Daniel Gough, Benyam Asefa, Ph.D., Chris Clarke, Ph.D., Katie Renn, Ricky Johnstone, Ph.D., Jonathan Keller, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1691.
https://doi.org/10.1182/blood.V104.11.1691.1691
Published: 2004
Journal Articles

C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo

Victoria Heath, Hyung Chan Suh, Matthew Holman, Katie Renn, John M. Gooya, Sarah Parkin, Kimberly D. Klarmann, Mariaestela Ortiz, Peter Johnson, Jonathan Keller
Journal: Blood
Blood (2004) 104 (6): 1639–1647.
https://doi.org/10.1182/blood-2003-11-3963
Published: 2004